Malignant lymphomas of the nasal cavity and nasopharynx: Clinicopathologic study of 113 cases, identifying CD56 expression as an unfavorable prognostic factor.

被引：0
|
作者：
Chan, JKC
Cheung, MMC
Ng, CS
Fu, WWL
Lau, WH
机构：
[1] QUEEN ELIZABETH HOSP,HONG KONG,HONG KONG
[2] CARITAS MED CTR,HONG KONG,HONG KONG
来源：
LABORATORY INVESTIGATION | 1997年 / 76卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：707 / 707
页数：1
相关论文
共 8 条
  • [1] MALIGNANT-LYMPHOMAS AND RELATED CONDITIONS INVOLVING NASAL CAVITY AND PARA-NASAL SINUSES - A CLINICOPATHOLOGIC STUDY OF 42 CASES WITH EMPHASIS ON PROGNOSTIC FACTORS
    MAEDA, H
    AOZASA, K
    TSUJIMURA, T
    SASAKI, R
    YOSHIDA, J
    MATSUNAGA, T
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1988, 14 (01): : 9 - 15
  • [2] NON-EPITHELIAL TUMORS OF THE NASAL CAVITY, PARA-NASAL SINUSES AND NASOPHARYNX - CLINICOPATHOLOGIC STUDY .10. MALIGNANT-LYMPHOMAS
    FU, YS
    PERZIN, KH
    CANCER, 1979, 43 (02) : 611 - 621
  • [3] Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts
    Ono, Takaaki
    Takeshita, Akihiro
    Kishimoto, Yuji
    Kiyoi, Hitoshi
    Okada, Masaya
    Yamauchi, Takahiro
    Emi, Nobuhiko
    Horikawa, Kentaro
    Matsuda, Mitsuhiro
    Shinagawa, Katsuji
    Monma, Fumihiko
    Ohtake, Shigeki
    Nakaseko, Chiaki
    Takahashi, Masatomo
    Kimura, Yukihiko
    Iwanaga, Masako
    Asou, Norio
    Naoe, Tomoki
    CANCER SCIENCE, 2014, 105 (01) : 97 - 104
  • [4] Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
    Natkunam, Y
    Warnke, RA
    Haghighi, B
    Su, LD
    Le Boit, PE
    Kim, YH
    Kohler, S
    JOURNAL OF CUTANEOUS PATHOLOGY, 2000, 27 (08) : 392 - 399
  • [5] CD56 Is an Unfavorable Prognostic Factor for Acute Promyelocytic Leukemia: Results By Multivariate Analyses in the JALSG-APL204 Study
    Takeshita, Akihiro
    Asou, Norio
    Atsuta, Yoshiko
    Furumaki, Hiroaki
    Sakura, Toru
    Ueda, Yasunori
    Sawa, Masashi
    Dobashi, Nobuaki
    Suzuki, Rikio
    Taniguchi, Yasuhiro
    Nakagawa, Masaru
    Tamaki, Shigehisa
    Hagihara, Maki
    Fujimaki, Katsumichi
    Yokoyama, Yasuhisa
    Fujita, Hiroyuki
    Yanada, Masamitsu
    Maeda, Yoshinobu
    Usui, Noriko
    Kobayashi, Yukio
    Kiyoi, Hitoshi
    Ohtake, Shigeki
    Matsumura, Itaru
    Naoe, Tomoki
    Miyazaki, Yasushi
    BLOOD, 2018, 132
  • [6] Prognostic relevance of CD56 expression in multiple myeloma: A study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant
    Chang, H
    Samiee, S
    Yi, QL
    LEUKEMIA & LYMPHOMA, 2006, 47 (01) : 43 - 47
  • [7] Expression of CD56 Is an Independent Prognostic Factor to Predict Relapse in Acute Myeloid Leukemia with t(8;21): Results of Japan Adult Leukemia Study Group (JALSG) AML97 Protocol
    Iriyama, Noriyoshi
    Hatta, Yoshihiro
    Takeuchi, Jin
    Ogawa, Yoshiaki
    Ohtake, Shigeki
    Sakura, Toru
    Mitani, Kinuko
    Ishida, Fumihiro
    Takahashi, Masatomo
    Maeda, Tomoya
    Izumi, Tohru
    Sakamaki, Hisashi
    Miyawaki, Shuichi
    Honda, Sumihisa
    Miyazaki, Yasushi
    Taki, Tomohiko
    Taniwaki, Masafumi
    Naoe, Tomoki
    BLOOD, 2012, 120 (21)
  • [8] CD56, Cyclin D1, p53 and p21 antigen expression in plasma cells as a prognostic factor of chronic kidney disease in 122 bone marrow biopsies cases of multiple myeloma
    Nazarovs, J.
    Kleina, R.
    Lejniece, S.
    VIRCHOWS ARCHIV, 2018, 473 : S269 - S269
1